Women’s Multivitamin Gummies
Food supplement declared in France, decision dated 11 August 2025
Women’s Multivitamin Gummies (NOVOMINS) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Lactobacillus Acidophilus LA85 1,000,000 (unit not declared) per day, Bifidobacterium Infantis BL21 1,000,000 (unit not declared) per day, Pantothenic acid (vitamin B5), Biotin (vitamin B8), Calcium. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- NOVOMINS
- Food business operator placing the product on the market
- INNOCENT HEALTH LTD
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Chewing gum
- Daily dose
- 2 gommes
- Directions for use
- Prendre 2 gommes par jour ou selon les recommandations de votre professionnel de santé.
- Flavourings
- mûre
Declaration 338282, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Substances
| Name | Per day |
|---|---|
| collagène | not declared |
Other active ingredients
| Name | Per day |
|---|---|
| Bitartrate de choline | not declared |
| Fibres d'agrumes | not declared |
| Ubiquinone | not declared |
| Hyaluronate de sodium | not declared |
Micro-organisms
| Strain | Per day |
|---|---|
| Lactobacillus Acidophilus LA85 | 1,000,000 (unit not declared) |
| Bifidobacterium Infantis BL21 | 1,000,000 (unit not declared) |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-pantothenate, calcium | Pantothenic acid (vitamin B5) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| D-biotin | Biotin (vitamin B8) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| calcium salts of orthophosphoric acid | Calcium | 2,500 mg | 800 mg |
| chromium picolinate | Chromium | no limit (insufficient data) | 25 µg |
| cupric gluconate | Copper | 5,000 µg | 2,000 µg |
| pteroylmonoglutamic acid | Folate (vitamin B9) | 1,000 µg | 200 µg |
| potassium iodide | Iodine | 600 µg | 150 µg |
| sodium selenite | Selenium | 255 µg | 50 µg |
| retinyl acetate | Vitamin A | 3,000 µg d'équivalent rétinol | 800 µg |
| cyanocobalamin | Vitamin B12 | no adverse effect defined | dose annulled by the French Council of State in 2011 |
| pyridoxine hydrochloride | Vitamin B6 | 12 mg | 2 mg |
| L-ascorbic acid | Vitamin C | no limit (insufficient data) | 180 mg |
| cholecalciferol | Vitamin D | 100 µg (4,000 IU) | 5 µg (200 IU) |
| DL-alpha-tocopheryl acetate | Vitamin E | 300 mg | 30 mg |
| menaquinone | Vitamin K | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| zinc citrate | Zinc | 25 mg | 15 mg |
Additives
E903, E331, E330, E440, E960, E1200, E953, E965
Other ingredients
jus de carotte, Huile de coco
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Les compléments alimentaires ne doivent pas être utilisés en remplacement d'une alimentation équilibrée et variée et d'un mode de vie sain. Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des jeunes enfants. Si vous êtes prenez des médicaments ou êtes sous surveillance médicale, veuillez consulter votre médecin ou un professionnel de la santé avant toute utilisation. Cessez l’utilisation et contactez un médecin immédiatement si des eets indésirables se produisent. Les gummies sont destinés à être mâchés et non à être avalés entiers. Déconseillé aux femmes enceintes ou désireuses de l’être. Déconseillé aux femmes ménopausées. Déconseillé aux personnes sous traitement anticoagulant. Déconseillé aux personnes souffrant de troubles de la thyroïde. Usage prolongé déconseillé. Réservée aux adultes. Ce produit ne convient pas aux végétariens. Une consommation excessive peut avoir des effets laxatifs.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Ubiquinone
Read the warning, when it applies and the studies cited
Coenzyme Q10 (UBIQUINONE-10)
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
Sources cited by Health Canada (2)
- Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
- Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial
Applies to products providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
Sources cited by Health Canada (3)
- Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
- Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
- Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report
Condition of application: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Women’s Multivitamin Gummies Forcelab, declared in 2026 : different composition: 5 ingredient(s) added, 24 missing
Brand : NOVOMINS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Women’s Multivitamin Gummies (NOVOMINS): composition and regulation”, https://compoatlas.com/en/supplements/products/338282-women-s-multivitamin-gummies, updated 15 November 2026.